| Literature DB >> 36056254 |
Yohana Camila Garay1, Romina Beatriz Cejas2, Virginia Lorenz3, Natacha Zlocowski4, Pedro Parodi1, Franco Alejandro Ferrero1, Genaro Angeloni1, Valentina Alfonso García1, Victor German Sendra5, Ricardo Dante Lardone1, Fernando José Irazoqui6.
Abstract
Polypeptide N-acetylgalactosamine transferase 3 (ppGalNAc-T3) is an enzyme involved in the initiation of O-GalNAc glycan biosynthesis. Acting as a writer of frequent post-translational modification (PTM) on human proteins, ppGalNAc-T3 has key functions in the homeostasis of human cells and tissues. We review the relevant roles of this molecule in the biosynthesis of O-GalNAc glycans, as well as in biological functions related to human physiological and pathological conditions. With main emphasis in ppGalNAc-T3, we draw attention to the different ways involved in the modulation of ppGalNAc-Ts enzymatic activity. In addition, we take notice on recent reports of ppGalNAc-T3 having different subcellular localizations, highlight critical intrinsic and extrinsic functions in cellular physiology that are exerted by ppGalNAc-T3-synthesized PTMs, and provide an update on several human pathologies associated with dysfunctional ppGalNAc-T3. Finally, we propose biotechnological tools as new therapeutic options for the treatment of pathologies related to altered ppGalNAc-T3. KEY MESSAGES: ppGalNAc-T3 is a key enzyme in the human O-GalNAc glycans biosynthesis. enzyme activity is regulated by PTMs, lectin domain and protein-protein interactions. ppGalNAc-T3 is located in human Golgi apparatus and cell nucleus. ppGalNAc-T3 has a central role in cell physiology as well as in several pathologies. Biotechnological tools for pathological management are proposed.Entities:
Keywords: Glycobiology; Glycosyltransferases; O-Glycans; Post-translational modifications; Potential therapies
Mesh:
Substances:
Year: 2022 PMID: 36056254 DOI: 10.1007/s00109-022-02249-5
Source DB: PubMed Journal: J Mol Med (Berl) ISSN: 0946-2716 Impact factor: 5.606